首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1374796

全球胸腔引流裝置市場-2023-2030

Global Thoracic Drainage Devices Market -2023-2030

出版日期: 2023年11月01日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

由於患者對微創技術的偏好而轉向微創胸腔引流手術等趨勢預計將主導全球胸腔引流設備市場。

近年來，全球胸腔引流裝置市場顯著成長，預計將持續維持上升趨勢。市場正在經歷一個轉型期，受到幾個重要趨勢的影響，例如配備連接功能的胸腔引流系統數位化，允許即時監控患者、遠端資料存取和改進患者管理。

此外，胸部疾病盛行率不斷上升，胸腔引流裝置技術的不斷進步，提高了其效率和安全性，且胸腔手術（包括肺切除和移植）的數量不斷增加，需要胸腔引流裝置進行術後護理，從而推動了胸腔引流裝置的使用。排水設備市場規模。新技術研究活動的不斷成長以及製藥醫療技術公司的存在是北美地區需求的一些因素。 ATMOS MedizinTechnik GmbH & Co. K、Becton、Dickinson and Company 等重要競爭對手以及其他在市場上積極運作的公司。

動力學

胸腔手術數量的增加推動胸腔引流裝置市場的成長

胸腔手術數量的增加是推動胸腔引流裝置市場的重要因素。這些裝置在心胸外科手術中至關重要，因為它們可以從心包膜和胸膜腔中排出血液、液體和空氣，減少術後問題，並最大限度地減少積液、填塞、氣胸和出血等問題。在改進的數位引流設備開發之前，經典的三腔吸引技術是過去五年胸腔外科的標準。

例如，根據美國國家醫學圖書館2022 年發表的一篇文章，光是在美國，每年就有約53 萬例普通胸腔外科手術由約4,000 名心胸外科醫師進行，其中大多數是男性（92%），平均年齡56歲。胸腔外科醫師平均每年為 135 名患者進行手術。胸部手術的增加強調了市場在改善患者護理和治療效果方面的成長潛力。

技術進步將推動胸腔引流裝置市場成長

包括先進設計的胸腔引流裝置的不斷進步預計將推動市場的發展。例如，2023 年 9 月，Merit Medical Systems, Inc. 宣布推出 Aspira 真空引流瓶。 Aspira 引流系統用於治療復發性和有症狀的胸腔積液（肺外液體積聚）和惡性腹水（癌症引起的腹部液體積聚）。

此外，Aspira 引流系統用於引流經常需要院內引流的複發性胸腔積液和惡性腹水的適應症顯示了尖端引流技術在改善病患照護和生活品質方面的關鍵作用。因此，隨著越來越多的醫療機構和專業人員採用尖端解決方案，在預測期內提高效率、精度和患者治療效果的技術改進的推動下，胸腔引流設備市場預計將成長。

缺乏熟練的專業人員將阻礙市場的成長

缺乏熟練的專業人員是這個市場的主要限制。胸腔引流是一種先進的外科手術，需要跨學科協作，護理師在胸管插入和護理中發揮重要作用。然而，住院醫師插入的胸管經常會出現問題，強調需要進一步訓練。

此外，胸管插入是放射科醫師、肺科專家和胸腔外科醫師執行的常見手術。根據北美放射學會2022年的文章，英國放射科醫生短缺，因為歐洲每10萬人就有13名放射科醫生，但英國的比例僅為每10萬人8.5名。因此，由於這一因素，預計市場將在預測期內成長。

The global thoracic drainage devices market has grown significantly in recent years and is projected to continue on its upward trend. The market is undergoing a transformational period, influenced by several significant trends such as digitalization in chest drainage systems equipped with connectivity features allowing real-time monitoring of patients, remote data access, and improved patient management.

Furthermore, the rising prevalence of thoracic diseases, Continuous technological advancements in thoracic drainage devices have improved their efficiency and safety and increasing number of thoracic surgeries, including lung resections and transplantations, that requires thoracic drainage devices for post-operative care are driving up the thoracic drainage devices market size. The growing research activities for new technologies and presence of establish pharmaceutical medtech companies are some of the factors in demand from North American regions. With significant competitors like ATMOS MedizinTechnik GmbH & Co. K, Becton, Dickinson and Company, and others actively operating in the market.

Dynamics

The Increasing Number of Thoracic Surgeries to Drive the Growth of the Thoracic Drainage Devices Market

The increasing number of thoracic surgeries is an important factor driving in the market for thoracic drainage devices. These devices are essential in cardiothoracic surgery because they allow for the drainage of blood, fluids, and air from the pericardial and pleural cavities, reducing post-operative problems and minimizing concerns such as effusions, tamponade, pneumothoraces, and hemorrhage. Prior to the development of improved digital drainage devices, the classic 3-chamber suction technique was the standard in thoracic surgery for the past five decades.

For instance, according to a National Library of Medicine article published in 2022, states that about 530,000 general thoracic surgery cases are performed annually in the U.S alone by approximately 4,000 cardiothoracic surgeons, the majority of them are male (92%), with an average age of 56 years. The average thoracic surgeon performs 135 patients per year. This increase in thoracic procedures emphasizes the market's potential for growth in enhancing patient care and outcomes.

The Advancements in Technologies will Drive the Thoracic Drainage Devices Market Growth

The growing advancements in thoracic drainage devices emcompassing advanced design is expected to drive the market. For instance, in September 2023, Merit Medical Systems, Inc. announced the launch of its Aspira Evacuated Drainage Bottle. The Aspira Drainage System is used to treat recurring and symptomatic pleural effusions (fluid buildup outside the lungs) and malignant ascites (fluid buildup in the abdomen caused by cancer).

Furthermore, the indications for the Aspira Drainage System for draining recurrent pleural effusions and malignant ascites, both of which frequently require in-hospital drainage, show the crucial role of cutting-edge drainage technologies in improving patient care and quality of life. Thus, as more healthcare organizations and professionals adopt cutting-edge solutions, the market for thoracic drainage devices is expected to grow, fueled by technological improvements that improve efficiency, precision, and patient outcomes over the forecast period.

The Lack of Availability of Skilled Professional Will Hamper the Growth of the Market

The lack of availability of skilled professional is the major restraint for this market. Thoracic drainage is an advanced surgical procedure that requires interdisciplinary collaboration, and nurses play a significant role in chest tube insertion and care. However, chest tubes inserted by resident physicians are frequently associated with problems, emphasizing the need for further training.

Furthermore, chest tube insertion is a common procedure performed by radiologists, pulmonary specialists, and thoracic surgeons. According to the Radiological Society of North America 2022 article, there is a shortage of radiologists in the U.K, since Europe has 13 radiologists per 100,000 people, but the rate in the U.K. is only 8.5 per 100,000. Thus, owing to this factor the market is expected to grow over the forecast period.

Segment Analysis

The global thoracic drainage devices market is segmented based on product, material type, application, end user and region.

Owing to the Better Effectiveness and Variety, the Chest Drainage Systems Segment Accounted for Approximately 47.2% of the Thoracic Drainage Devices Market Share

The chest drainage systems segment is expected to dominate the thoracic drainage device market. These systems are widely used in a variety of clinical settings, including cardiac surgery, cardiothoracic surgery, pulmonology, and critical care, to treat diseases such as pleural effusion, pneumothorax, hemothorax, and post-operative drainage.

This segment's is dominated due to the variety and effectiveness of chest drainage devices in removing air and fluids from the pleural area, hence aiding lung re-expansion and reducing problems. Furthermore, contemporary technological advancements in digital chest drainage systems, which allow for real-time monitoring and enhanced patient management, contribute to their widespread acceptability.

For instance, in July 2022, Centese, Inc. announced the first peer-reviewed study for its Thoraguard digital drainage system for cardiac surgery at Stanford University Medical Center, which was published in the Journal of Thoracic and Cardiovascular Surgery Open. Thoraguard is the first and only digital chest tube management system that delivers automated clog removal without human intervention while continuously and precisely monitoring vital physiological indicators to support clinical decision-making and enhance outcomes. Furthermore, when utilized during heart surgery, Thoraguard was demonstrated to be safe and efficacious when compared to standard analog chest tubes. Thus, owing to the above factors the segment is expected to dominate over the forecast period.

Geographical Penetration

North America Accounted for Approximately 38.2% of the Market Share in 2022, Owing to the Increasing Number of Clinical Trials

The increasing number of clinical trials in North America is expected to dominate the thoracic drainage device market. Clinical trials play a vital role in determining the safety and efficacy of novel devices. For instance, the University of Oklahoma is conducting a clinical trial comparing the Digital Chest Tube Drainage System (Thopaz + ) to the Analog in Pediatric Patients." The purpose of the research is to assess the efficacy of digital (Thopaz + ) and analog (Pleur-evac) drainage devices in pediatric patients. The trial is an interventional, randomized, and controlled study that is expected to enroll 140 people.

Furthermore, the study is expected to be finished by April 1, 2024 and there have been no prospective randomized controlled trials comparing digital versus analog chest tube drainage systems in pediatric patients so far. This will be the first prospective randomized trial to look into the possible benefits of adopting a digital chest tube drainage system in pediatric patients.

Moreover, the increasing prevalence of chronic diseases in North America is also expected to drive the market. Chronic diseases such as heart disease and pulmonology disease are significant drivers of demand for thoracic drainage devices. As the population ages and lifestyle factors increase the prevalence of chronic diseases, the need for appropriate thoracic drainage treatments grows. Thus, owing to the above factors the region is expected to dominate over the forecast period.

Competitive Landscape

The major global players in the thoracic drainage devices market include: ATMOS MedizinTechnik GmbH & Co. K, Becton, Dickinson and Company, Cardinal Health., Cook Group Incorporated, Getinge AB, Sinapi Biomedical, Teleflex Incorporated, Utah Medical Products, Inc., Vygon SA, Sterimed Group, and among others.

COVID-19 Impact Analysis

The World Health Organization (WHO) reported more roughly 585.0 million confirmed COVID-19 cases as of August 2022, with around 6.4 million recorded deaths. However, research has shown that thoracic drainage systems play an important role in preventing the widespread development of COVID-19. Individuals with COVID-19 are at a higher risk of having acute respiratory distress syndrome (ARDS), which requires invasive mechanical ventilation.

Furthermore, COVID-19-related barotrauma frequently results in pneumothorax, necessitating chest tube insertion (thoracostomy). Furthermore, members of the German Health Alliance (GHA), which include prominent companies such as B. Braun, ATMOS MedizinTechnik GmbH & Co. KG, Getinge, and Drager, have seen a significant increase in global demand for their products, particularly thoracic drainage systems, since the beginning of 2020. ATMOS MedizinTechnik GmbH & Co. KG, for example, an innovative medical device maker, has increased production to meet increased demand, realizing that product categories such as drainage systems play a critical role in saving lives in the face of the COVID-19 epidemic.

Key Developments

On April 18, 2022, Merit Medical Systems, Inc., a global leader in the manufacture and marketing of healthcare technologies, stated the launch of the ReSolve Thoracostomy Tray. The new tray includes everything needed to execute a thoracostomy, a minimally invasive method that allows patients to avoid open surgery to drain fluids or air from the chest.
On December 15, 2020, Medela LLC stated that their Thopaz + Digital Chest Drainage and Monitoring System completed various quantitative tests demonstrating that its filtration system efficiently inhibits the passage of aerosolized viral particles such as SARS-CoV-2, the virus responsible for COVID-19.

Why Purchase the Report?

To visualize the global thoracic drainage devices market segmentation based on product, material type, application, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of thoracic drainage devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in excel consisting of key products of all the major players.

The global thoracic drainage devices market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Material Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The Increasing Number of Thoracic Surgeries
  - 4.1.1.2. The Advancements in Technologies
- 4.1.2. Restraints
  - 4.1.2.1. The Lack of Availability of Skilled Professional
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Chest Drainage Systems*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 7.2.2.1. Water Seal Chest Drainage Systems
  - 7.2.2.2. Dry Seal Chest Drainage Systems
  - 7.2.2.3. Digital Chest Drainage Systems
7.3. Thoracic Drainage Kits
7.4. Pleural Drainage Catheters
- 7.4.1. Thoracentesis Catheters
- 7.4.2. Paracentesis Catheters
- 7.4.3. Others
7.5. Trocar Drains
7.6. Others

8. By Material Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 8.1.2. Market Attractiveness Index, By Material Type
8.2. Silicone*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Polyurethane
8.4. Latex
8.5. Other

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Cardiac Surgery*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Oncology & Pain Management
9.4. Thoracic Surgery & Pulmonology
9.5. General Intensive Care Emergency Medicine
9.6. Others

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgery Centers
10.4. Cardiac Specialty Clinics
10.5. Cardiothoracic Centers
10.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. U.K.
  - 11.3.7.3. France
  - 11.3.7.4. Spain
  - 11.3.7.5. Italy
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. ATMOS MedizinTechnik GmbH & Co. K*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Becton, Dickinson and Company
13.3. Cardinal Health.
13.4. Cook Group Incorporated
13.5. Getinge AB
13.6. Sinapi Biomedical
13.7. Teleflex Incorporated
13.8. Utah Medical Products, Inc.
13.9. Vygon SA
13.10. Sterimed Group

LIST NOT EXHAUSTIVE